Rare diseases
Investigational molecules
Locations
A study to test the safety and effectiveness of BAY 3713372 alone and with drug combination in patients with MTAP-deleted solid tumors
BelgiumStudy of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy
BelgiumA study comparing erdafitinib delivery system to chemotherapy for patients with high-risk non-muscle-invasive bladder cancer who received BCG treatment
BelgiumVorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy
BelgiumA Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment
BelgiumA study testing the reduction of heart failure drug combination in patients with heart failure in remission
BelgiumStudy of RSV vaccine and nirsevimab combination to prevent RSV infection in infants up to 12 months of age
BelgiumA Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment
BelgiumA Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema
BelgiumA Study Testing Prolonged versus Single Dose Penicillin Challenge in Patients with Suspected Penicillin Allergy Using Amoxicillin
BelgiumA Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
BelgiumStudy of Different Dosing Schedules of Osimertinib in Patients with EGFR Mutated Advanced or Metastatic Non-Small Cell Lung Cancer
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
